JP2005526085A5 - - Google Patents

Download PDF

Info

Publication number
JP2005526085A5
JP2005526085A5 JP2003575997A JP2003575997A JP2005526085A5 JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5 JP 2003575997 A JP2003575997 A JP 2003575997A JP 2003575997 A JP2003575997 A JP 2003575997A JP 2005526085 A5 JP2005526085 A5 JP 2005526085A5
Authority
JP
Japan
Prior art keywords
vaccine
quinolin
imidazo
antigen
amine derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003575997A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005526085A (ja
Filing date
Publication date
Priority claimed from GBGB0206461.6A external-priority patent/GB0206461D0/en
Application filed filed Critical
Publication of JP2005526085A publication Critical patent/JP2005526085A/ja
Publication of JP2005526085A5 publication Critical patent/JP2005526085A5/ja
Pending legal-status Critical Current

Links

JP2003575997A 2002-03-19 2003-03-18 ワクチン接種の改良 Pending JP2005526085A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0206461.6A GB0206461D0 (en) 2002-03-19 2002-03-19 Improvements in vaccination
PCT/EP2003/002878 WO2003077944A1 (en) 2002-03-19 2003-03-18 Improvements in vaccination

Publications (2)

Publication Number Publication Date
JP2005526085A JP2005526085A (ja) 2005-09-02
JP2005526085A5 true JP2005526085A5 (https=) 2006-03-30

Family

ID=9933281

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003575997A Pending JP2005526085A (ja) 2002-03-19 2003-03-18 ワクチン接種の改良

Country Status (7)

Country Link
US (2) US20050143284A1 (https=)
EP (1) EP1485125A1 (https=)
JP (1) JP2005526085A (https=)
AU (1) AU2003212369A1 (https=)
CA (1) CA2479315A1 (https=)
GB (1) GB0206461D0 (https=)
WO (1) WO2003077944A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1487485T3 (da) * 2002-03-19 2011-03-14 Powderject Res Ltd Imidazoquinolinadjuvanser til DNA-vacciner
CA2510375A1 (en) 2002-12-20 2004-07-15 3M Innovative Properties Company Aryl / hetaryl substituted imidazoquinolines
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
CN1852711A (zh) * 2003-08-05 2006-10-25 3M创新有限公司 使用免疫响应调节化合物的传染病预防
JP2007504145A (ja) * 2003-08-25 2007-03-01 スリーエム イノベイティブ プロパティズ カンパニー 免疫刺激性の組み合わせおよび治療
AR046046A1 (es) 2003-10-03 2005-11-23 3M Innovative Properties Co Imidazoquinolinas alcoxi sustituidas. composiciones farmaceuticas.
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
EA012066B1 (ru) * 2003-10-10 2009-08-28 Паудерджект Вэксинс, Инк. Способ, вызывающий т-клеточный ответ
CA2547020C (en) 2003-11-25 2014-03-25 3M Innovative Properties Company 1h-imidazo[4,5-c]pyridine-4-amine derivatives as immune response modifier
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
CN101304748A (zh) 2005-08-22 2008-11-12 加利福尼亚大学董事会 Tlr激动剂
EA200800782A1 (ru) 2005-09-09 2008-08-29 Коли Фармасьютикал Груп, Инк. ПРОИЗВОДНЫЕ АМИДА И КАРБАМАТА N-{2-[4-АМИНО-2-(ЭТОКСИМЕТИЛ)-1Н-ИМИДАЗОЛО[4,5-c]ХИНОЛИН-1-IL]-1,1-ДИМЕТИЛЭТИЛ}МЕТАНСУЛЬФОНАМИДА И СПОСОБЫ
ZA200803029B (en) 2005-09-09 2009-02-25 Coley Pharm Group Inc Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
KR20080083270A (ko) 2005-11-04 2008-09-17 콜레이 파마시티컬 그룹, 인코포레이티드 하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
US8329721B2 (en) 2006-03-15 2012-12-11 3M Innovative Properties Company Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
US8088788B2 (en) 2006-03-15 2012-01-03 3M Innovative Properties Company Substituted fused[1,2] imidazo[4,5-c] ring compounds and methods
EP2700638A1 (en) 2006-05-31 2014-02-26 The Regents Of the University of California Purine analogs
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
CN101790380B (zh) 2007-02-07 2013-07-10 加利福尼亚大学董事会 合成tlr激动剂的缀合物及其应用
EP3067048B1 (en) 2007-12-07 2018-02-14 GlaxoSmithKline Biologicals SA Compositions for inducing immune responses
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US6558951B1 (en) * 1999-02-11 2003-05-06 3M Innovative Properties Company Maturation of dendritic cells with immune response modifying compounds
GB0023008D0 (en) * 2000-09-20 2000-11-01 Glaxo Group Ltd Improvements in vaccination

Similar Documents

Publication Publication Date Title
JP2005526085A5 (https=)
CN105491982B (zh) 用于增强透皮递送的肽
DK1509521T3 (da) 1H-Imidazol[4,5-c]quinolinderivater til behandling af proteinkinaseafhænige sygdomme
JP2005537234A5 (https=)
AR035586A1 (es) Composicion de vacuna, equipo, metodos para incrementar la respuesta inmune, uso de un derivado de 1h-imidazo(4,5-c)quinolin-4-amina en la fabricacion de un medicamento, y combinacion de componentes para la administracion separada, secuencial o concomitante para el uso en la vacunacion de adn
WO2005065319A3 (en) Generally linear effervescent oral fentanyl dosage form and methods of administering
JP2007534728A5 (https=)
WO2003090686A3 (en) Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality
HRP20140102T1 (hr) Cjepivo za prevenciju relapsa raka dojke
CA2514224A1 (en) Liquid pharmaceutical formulations of palonosetron
AR035867A1 (es) Una particula semejante a un virus hcv formada por una proteina de envoltura de hcv, un metodo para formar dicha particula, un medicamento que la contiene, una vacuna, un metodo de deteccion, un kit de diagnostico, el uso de cepas de hansenula o saccharomyces para la expresion de una proteina hcv, e
ITMI20031617A1 (it) Microcapsule a doppio strato di polisaccaridi utilizzabili
WO2005010022A3 (en) Agonist polypeptide of receptor for zot and zonulin
WO2005084306A3 (en) Immunogenic compositions for chlamydia pneunomiae
EP1491210A4 (en) THERAPEUTIC MEDICAMENT USING ANTIBODY PRESENTING HOLES PROTEIN NANOTEHICLES AND HIGH PROTEIN NANOTEHICLES
DK1173476T3 (da) Funktionelle sojabönneproteiner
EA200400591A1 (ru) СПОСОБ ВВЕДЕНИЯ ПЕПТИДА ТИМОЗИН α1
HUP0400340A2 (hu) Polipeptidek immunogenitásának csökkentésére szolgáló eljárások
NO20053788D0 (no) Anvendelse av lupin-konglutin for behandlingen av type II diabetes.
DE60112584D1 (de) Verfahren zur Herstellung einer flüssigen Dosierungseinheit und Kit
EP1583545A4 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF PEPTIDES OF HIV GP41 AND ITS THERAPEUTIC USE
MXPA05012826A (es) Compuestos utiles en la terapia de la enfermedad de alzheimer y formulaciones que los contienen.
ZA200500556B (en) The pharmaceutical formulation of traditional chinese medicine for abstinence of drug and preparation method and use thereof
NZ592114A (en) Composition comprising sortase anchored surface proteins of streptococcus uberis
DE602005010844D1 (de) Pharmazeutische zusammensetzungen mit interferon-tau